Motif Neurotech

📖🧠Motif Minds: Nick Halper, COO 🧠 📖 We're excited to bring you an in-depth interview with our newly appointed Chief Operating Officer, Nick Halper. In this candid Q&A, Nick reveals his serendipitous journey to Motif, offers insights into the dynamic challenges of a neurotechnology startup and shares his thoughts on the future of therapeutic brain-computer interfaces. Meet the minds shaping the future of neurotechnology and mental health treatment!

Our newly named Director of Lived Experience, Jon Nelson, sat down with The Fit Mess Podcast to talk about his journey from suicidal despair to remission with the help of neurotechnology. He talks about why societal attitudes toward mental illness are deadly, and shares practical insights on supporting those struggling with depression. We are so fortunate to have Jon and others on our community advisory board to continuously reorient our team's work back towards our future patient's experience. Together, we can fight silence with science. 🤝 Listen here or wherever you get your podcasts ➡ ➡ ➡ https://lnkd.in/g4USfkik

There are only 5 days left to cast your vote for #SXSW 2025 #PanelPicker. We'd love your vote for our proposals on #mentalhealth and #MCI / healthy #aging. The Future of Mental Health: Precision Neuromedicine: VOTE: https://lnkd.in/g2PXc4-r Featuring: Samantha Tabone, Partner, Focalpoint Partners 💊 Sam Banister, CSO & Co-founder, Psylo Jacob Robinson, CEO & Co-Founder, Motif Neurotech Ryan Field, CEO & CTO, Kernel Detecting and Delaying the Onset of Cognitive Decline: VOTE: https://lnkd.in/gBBjdMit Featuring Phyllis Ferrell, Chief Impact Officer, StartUp Health #AlzMoonshot Ken Mariash, CEO, Sinaptica Therapeutics Jen Flexman, PhD, MBA, COO & Co-founder, Moneta Health Ryan Field, CEO & CTO, Kernel

🧠 Neurotech Job Opportunity 🧠 We're seeking a Manufacturing Technician to join our Houston-based team in prototyping, testing and assembling the next generation of mental health MedTech. As our Manufacturing Technician, you'll: 🔨 Build cutting-edge medical device prototypes 🏭 Master precision manufacturing techniques 🥇 Conduct rigorous quality testing 🔌 Contribute to R&D and production processes Come contribute to the forefront of neurotechnology and join us in creating a future where technology enables better mental health treatment! #neurotech #hiring #BCI #neuroscience

QOTD: Does the fresco behind Jacob Robinson make him look smarter? Last week, our team had an inspiring time at Neuromodec NYC Neuromodulation 2024 at The City College of New York. We heard from psychiatrists and scientists working to understand how neural circuits are involved in mental illness and where brain stimulation fits into treatment. We also discovered plenty of cooperative work that aligns with our goals to scale our future therapy. Thank you for having us! 📸 : Steven Goetz

⭐️ Congratulations to our own VP Global Clinical, Regulatory, and Quality, Erika Ross Ellison for sharing insights about our work with brain-computer interface (BCI) technology at the recent IEEE Engineering Medicine and Biology Society Conference in Orlando, Florida.    Erika, who is President-Elect of IEEE EMBS, spoke on a panel titled “BCI State of the Art, Art of the Future.” She discussed our groundbreaking work using a DigitalBridge™, which uses AI to re-establish communication between the brain and the spinal cord after a spinal cord injury (SCI) to empower thought-controlled movement. Erika was joined by executives from Blackrock Neurotech, Motif Neurotech, Paradromics Inc., and Precision Neuroscience to discuss the future of #BCI technology.    IEEE EMBS is the world’s largest international society of biomedical engineers. We value the work EMBS does to bring together the brightest minds at the intersection of biology, medicine, and engineering to foster learning and collaboration. ✨   🙏 Special thanks to JoJo Platt for organizing the panel.   #EmpoweringMovement #SCI #BCI #DigitalBridge     *All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

Motif team is enjoying the Big Apple this week during the 2024 NYC Neuromodulation Conference. Thanks so much BGB Group and Amanda Eckel for hosting us and collaborating yesterday! 🍎 💡

MTV Cribs: Neurotech Edition coming soon...

☀ 📢 See you in Orlando!! 📢 ☀

If you read only one article today, make it this interview with Jon Nelson on his battle with treatment resistant depression. By demonstrating that a device can address illnesses like depression, our industry is proving that mental illness isn't a choice—it's a brain circuit disorder with electrical deficiencies. Breaking the silence around these conditions reveals a crucial truth: those battling mental illness deserve the same compassion as individuals fighting cancer or any other life-threatening disease. https://lnkd.in/gbSkKZ6S